Martinez-Molina C., Gich I., Diaz-Torné C., Park H.S., Feliu A., Vidal S., Corominas H.. Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific Reports. 2024; 14(1)DOI:10.1038/s41598-023-50379-8. PMID:38168532. IF:3.900(Q1/2D).

Ruiz Ramos J., Alquézar-Arbé A., Juanes Borrego A., Burillo Putze G., Aguiló S., Jacob J., Fernández C., Llorens P., Quero Espinosa F.D.B., Gordo Remartinez S., Hernando González R., Moreno Martín M., Sánchez Aroca S., Sara Knabe A., González González R., Carrión Fernández M., Artieda Larrañaga A., Adroher Muñoz M., Hong Cho J.-U., Escolar Martínez Berganza M.T., Gayoso Martín S., Sánchez Sindín G., Silva Penas M., Gómez y Gómez B., Arenos Sambro R., González del Castillo J., Miró Ò.. Short-term prognosis of polypharmacy in elderly patients treated in emergency departments: results from the EDEN project. Therapeutic Advances in Drug Safety. 2024; 15DOI:10.1177/20420986241228129. PMID:38323189. IF:3.400(Q2/4D).

Plaza, V, Eguíluz ,, Garin, N, Moragón , EM, Palomares, O, Dávila ,. EPI-SURVEY: Grade of Awareness Among Spanish Allergists, Hospital Pharmacists, and Pulmonologists of the Relevance of Bronchial Epithelium and Alarmins in the Pathogenesis and Management of Severe Asthma. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2024; 34(5)DOI:10.18176/jiaci.0997. PMID:39441048. IF:4.800(Q1/1D).

Garrido-Alejos, G, Saborit-Canals, G, Guarga, L, de Pando, T, Umbria, M, Oriol, A, Feliu, A, Pontes, C, Vallano, A. Evolution of Pharmacological Treatments and Associated Costs for Multiple Myeloma in the Public Healthcare System of Catalonia: A Retrospective Observational Study. Cancers. 2023; 15(22)DOI:10.3390/cancers15225338. PMID:38001598. IF:4.500(Q1/3D).

Vallez-Valero L., Gasó-Gago I., Marcos-Fendian Á., Garrido-Alejos G., Riera-Magallón A., Plaza Diaz A., Martinez-Molina C., Mangues-Bafalluy M.A., Corominas H.. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; 42(12)DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2.900(Q2/4D).

Nezvalova-Henriksen K., Langebrake C., Bauters T., Moreno-Martinez M.-E., Ahnfelt E., Ekelund H., Domingos V., Pires V., Bonnin A., Bojanic I., Cabrerizo Y., Terwel S., Tam A.. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group. BONE MARROW TRANSPLANTATION. 2023; 58(10)DOI:10.1038/s41409-023-02072-7. PMID:37528237. IF:4.500(Q1/2D).